CHEBI:194402 - satavaptan

ChEBI IDCHEBI:194402
ChEBI Namesatavaptan
Stars
DefinitionA vasopressin V2 receptor antagonist that has been shown to improve hyponatremia in patients with cirrhosis, congestive heart failure, and syndrome of inappropriate antidiuresis.
Last Modified20 February 2023
Submitterslaulederkind
DownloadsMolfile
FormulaC33H45N3O8S
Net Charge0
Average Mass643.803
Monoisotopic Mass643.29274
SMILESCCOc1ccc2c(c1)[C@]1(CC[C@H](OCCN3CCOCC3)CC1)C(=O)N2S(=O)(=O)c1ccc(C(=O)NC(C)(C)C)cc1OC
InChIInChI=1S/C33H45N3O8S/c1-6-43-25-8-9-27-26(22-25)33(13-11-24(12-14-33)44-20-17-35-15-18-42-19-16-35)31(38)36(27)45(39,40)29-10-7-23(21-28(29)41-5)30(37)34-32(2,3)4/h7-10,21-22,24H,6,11-20H2,1-5H3,(H,34,37)/t24-,33+
InChIKeyQKXJWFOKVQWEDZ-VCCCEUOBSA-N
Wikipedia
Roles Classification
Biological Role:
vasopressin receptor antagonist  Any drug which blocks vasopressin receptors.
Applications:
aquaretic  A class of diuretics which promote aquaresis (the excretion of water without electrolyte loss).
vasopressin receptor antagonist  Any drug which blocks vasopressin receptors.
ChEBI Ontology
Outgoing Relation(s)
satavaptan (CHEBI:194402) has role aquaretic (CHEBI:194423)
satavaptan (CHEBI:194402) has role vasopressin receptor antagonist (CHEBI:59680)
satavaptan (CHEBI:194402) is a aromatic ether (CHEBI:35618)
satavaptan (CHEBI:194402) is a benzamides (CHEBI:22702)
satavaptan (CHEBI:194402) is a monomethoxybenzene (CHEBI:25235)
satavaptan (CHEBI:194402) is a morpholines (CHEBI:38785)
satavaptan (CHEBI:194402) is a oxaspiro compound (CHEBI:37948)
satavaptan (CHEBI:194402) is a secondary carboxamide (CHEBI:140325)
satavaptan (CHEBI:194402) is a sulfonamide (CHEBI:35358)
IUPAC Name 
N-tert-butyl-4-[5'-ethoxy-4-(2-morpholin-4-ylethoxy)-2'-oxospiro[cyclohexane-1,3'-indole]-1'-yl]sulfonyl-3-methoxybenzamide
INNs  Source
satavaptanWHO MedNet
satavaptanumWHO MedNet
satavaptánWHO MedNet
satavaptanWHO MedNet
Synonyms  Source
SR121463SUBMITTER
SR-121463SUBMITTER
SR 121463ChEBI
Brand Name  Source
AquildaChEBI
Manual XrefsDatabases
DB14923DrugBank
HMDB0257503HMDB
SatavaptanWikipedia
Registry NumbersSources
CAS:185913-78-4DrugBank
Citations